Peking Union Medical College Hospital clinical trial pipeline

18 trials changed in the last 30 days: 1 stopped, 9 with notable changes, 8 with minor changes only.

1. Stopped

   Cohort Study on the Safety and Efficacy of XH-02 in Treating…Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

   Recruitment suspended

   Peking Union Medical College Hospital·Phase 2· NCT07540286· Registry history of NCT07540286 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

2. Notable

   PILOT-BTC · Polymeric Micellar Paclitaxel-Based Combination…PILOT-BTC · Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

   Enrollment reduced: 61 → 25 participants

   Also in this update: Primary completion pushed from Aug 12, 2026 to Aug 7, 2027; Enrollment reopened

   Peking Union Medical College Hospital·Phase 2· NCT07159204· Registry history of NCT07159204 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

3. Notable

   Hypofractionated Online Adaptive Radiotherapy of Breast Cancer

   Primary completion pushed from Jul 2026 to Jul 2027

   Also in this update: Study completion pushed from Dec 2026 to Dec 2027

   Peking Union Medical College Hospital·Phase 2· NCT06568705· Registry history of NCT06568705 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

4. Notable

   POASAC Study (Preoperative Anemia Severity and Classification…POASAC Study (Preoperative Anemia Severity and Classification Study)

   Primary completion pushed from Dec 31, 2026 to Dec 31, 2027

   Also in this update: Study completion pushed from Dec 31, 2027 to Dec 31, 2028

   Peking Union Medical College Hospital·Not specified· NCT06499974· Registry history of NCT06499974 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

5. Notable

   Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA)…Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) · Cystic Fibrosis

   Primary completion pushed from May 10, 2026 to Dec 13, 2026

   Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting

   Peking Union Medical College Hospital·Early Phase 1· NCT06963008· Registry history of NCT06963008 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

6. Notable

   BAO-G-02 · BAO-G Technique in Complex Aortic Aneurysm…BAO-G-02 · BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

   Phase changed: Phase 1 → not applicable

   Peking Union Medical College Hospital·Not applicable· NCT07141251· Registry history of NCT07141251 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

7. Notable

   NYHCC · 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma

   Recruitment opened

   Also in this update: Primary and study completion moved earlier from Jun 1, 2027 to Apr 1, 2027

   Peking Union Medical College Hospital·Phase 1/2· NCT07590336· Registry history of NCT07590336 on ClinicalTrials.gov (opens the registry)

   Oct 21, 2026

8. Notable

   Tegileridine for Postoperative Pain After Adolescent Scoliosis…Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery

   Recruitment opened

   Also in this update: Primary completion pushed from Jun 30, 2027 to Oct 30, 2027; Study completion pushed from Sep 30, 2027 to Dec 30, 2027

   Peking Union Medical College Hospital·Phase 4· NCT07229495· Registry history of NCT07229495 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

9. Notable

   AI-assisted Rare Disease Diagnosis

   Recruitment opened

   Peking Union Medical College Hospital·Not applicable· NCT07650799· Registry history of NCT07650799 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

10. Notable

    Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients…Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

    Recruitment opened

    Peking Union Medical College Hospital·Early Phase 1· NCT07485543· Registry history of NCT07485543 on ClinicalTrials.gov (opens the registry)

    Oct 1, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.